Skip to main content
. 2017 Jun 27;7:4292. doi: 10.1038/s41598-017-04612-w

Figure 3.

Figure 3

ACF inhibits GSC growth in a dose-dependent fashion, and its anti-growth effect is augmented by hypoxia or by expression of, double-mutant, oxygen stable, forms of HIF-1α or HIF-2α. Growth curves of HSR-GBM1 (A,B), HSR040622 (B,C), and HSR040821 (E,F) treated with 0 (DMSO), 1, 5, 10, and 25 μM ACF in normoxia (21% oxygen; A,C,E) and hypoxia (1% oxygen; B,D,F). (G,H) Growth curve for HSR-GBM1 GSCs expressing GFP (as control) or the oxygen stable, double mutant (DM), forms of HIF-1α or HIF-2α, and treated with ACF at 0 (DMSO), 1 μM or 5 μM significantly reduced cell growth over a four-day period in normoxia. (H) A bar-graph analysis of day 4 time point is shown in (G). (***p < 0.001, **p < 0.01; One way ANOVA with multiple comparisons; Mean +/− SEM of triplicates is shown in all analyses).